66 related articles for article (PubMed ID: 7984661)
1. Kynurenine and probenecid prevent quinolinic acid-induced neurotoxicity in rat corpus striatum.
Santamaría A; Altagracia M; Solís F; Kravzov J; Ordaz H; Gonzalez L; Ríos C
Proc West Pharmacol Soc; 1994; 37():29-30. PubMed ID: 7984661
[No Abstract] [Full Text] [Related]
2. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
3. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
Pérez-Severiano F; Rodríguez-Pérez M; Pedraza-Chaverrí J; Maldonado PD; Medina-Campos ON; Ortíz-Plata A; Sánchez-García A; Villeda-Hernández J; Galván-Arzate S; Aguilera P; Santamaría A
Neurochem Int; 2004 Dec; 45(8):1175-83. PubMed ID: 15380627
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of probenecid on circling behavior of rats with unilateral quinollinic acid induced striatal lesions.
Kravzov J; Santamaria A; Rios C; Flores A; Altagracia M
Proc West Pharmacol Soc; 1993; 36():255-7. PubMed ID: 8378385
[No Abstract] [Full Text] [Related]
5. Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats.
Santamaría A; Ríos C; Solís-Hernández F; Ordaz-Moreno J; González-Reynoso L; Altagracia M; Kravzov J
Neuropharmacology; 1996 Jan; 35(1):23-8. PubMed ID: 8684593
[TBL] [Abstract][Full Text] [Related]
6. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
7. Dapsone administration prevents quinolinate-induced neurotoxicity in rats.
Altagracia M; Kravzov J; Santamaría A; Ríos C; Ordaz H; Gonzalez L
Proc West Pharmacol Soc; 1994; 37():63. PubMed ID: 7984675
[No Abstract] [Full Text] [Related]
8. Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study.
Németh H; Robotka H; Kis Z; Rózsa E; Janáky T; Somlai C; Marosi M; Farkas T; Toldi J; Vécsei L
Neuropharmacology; 2004 Nov; 47(6):916-25. PubMed ID: 15527825
[TBL] [Abstract][Full Text] [Related]
9. Peroxynitrite decomposition catalyst, iron metalloporphyrin, reduces quinolinate-induced neurotoxicity in rats.
Santiago-López D; Vázquez-Román B; Pérez-de La Cruz V; Barrera D; Rembao D; Salinas-Lara C; Pedraza-Chaverrí J; Galván-Arzate S; Ali SF; Santamaría A
Synapse; 2004 Dec; 54(4):233-8. PubMed ID: 15484207
[No Abstract] [Full Text] [Related]
10. Neuroprotective effect of dapsone against quinolinate- and kainate-induced striatal neurotoxicities in rats.
Santamaría A; Ordaz-Moreno J; Rubio-Osornio M; Solís-Hernández F; Ríos C
Pharmacol Toxicol; 1997 Dec; 81(6):271-5. PubMed ID: 9444668
[TBL] [Abstract][Full Text] [Related]
11. Histological and behavioral protection by (-)-nicotine against quinolinic acid-induced neurodegeneration in the hippocampus.
O'Neill AB; Morgan SJ; Brioni JD
Neurobiol Learn Mem; 1998 Jan; 69(1):46-64. PubMed ID: 9521812
[TBL] [Abstract][Full Text] [Related]
12. Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid.
Knyihár-Csillik E; Toldi J; Krisztin-Péva B; Chadaide Z; Németh H; Fenyo R; Vécsei L
Neurosci Lett; 2007 May; 418(2):122-6. PubMed ID: 17382471
[TBL] [Abstract][Full Text] [Related]
13. Melatonin neutralizes neurotoxicity induced by quinolinic acid in brain tissue culture.
Vega-Naredo I; Poeggeler B; Sierra-Sánchez V; Caballero B; Tomás-Zapico C; Alvarez-García O; Tolivia D; Rodríguez-Colunga MJ; Coto-Montes A
J Pineal Res; 2005 Oct; 39(3):266-75. PubMed ID: 16150107
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxykynurenine toxicity on the rat striatum in vivo.
Nakagami Y; Saito H; Katsuki H
Jpn J Pharmacol; 1996 Jun; 71(2):183-6. PubMed ID: 8835646
[TBL] [Abstract][Full Text] [Related]
15. Deprenyl enhances the striatal neuronal damage produced by quinolinic acid.
de Pablos RM; Herrera AJ; Tomás-Camardiel M; Machado A; Cano J
Brain Res Mol Brain Res; 2005 Nov; 141(1):48-57. PubMed ID: 16202473
[TBL] [Abstract][Full Text] [Related]
16. l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.
Vámos E; Párdutz A; Varga H; Bohár Z; Tajti J; Fülöp F; Toldi J; Vécsei L
Neuropharmacology; 2009 Sep; 57(4):425-9. PubMed ID: 19580819
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory agents, tolmetin and sulindac, attenuate oxidative stress in rat brain homogenate and reduce quinolinic acid-induced neurodegeneration in rat hippocampal neurons.
Dairam A; Chetty P; Daya S
Metab Brain Dis; 2006 Sep; 21(2-3):221-33. PubMed ID: 16850258
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate.
Robotka H; Sas K; Agoston M; Rózsa E; Szénási G; Gigler G; Vécsei L; Toldi J
Life Sci; 2008 Apr; 82(17-18):915-9. PubMed ID: 18387638
[TBL] [Abstract][Full Text] [Related]
19. Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis.
Morrison PF; Morishige GM; Beagles KE; Heyes MP
J Neurochem; 1999 May; 72(5):2135-44. PubMed ID: 10217295
[TBL] [Abstract][Full Text] [Related]
20. The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.
Miller JM; MacGarvey U; Beal MF
Neurosci Lett; 1992 Oct; 146(1):115-8. PubMed ID: 1475044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
